Structure |
Chemical Name |
CAS |
MF |
![4-ethoxy-3-(4-pyridyl)-3-buten-2-one](/CAS/GIF/88349-61-5.gif) |
4-ethoxy-3-(4-pyridyl)-3-buten-2-one |
88349-61-5 |
C11H13NO2 |
![1,3-Dihydro-4-methyl-2H-1,5-benzodiazepin-2-on](/CAS/GIF/6276-48-8.gif) |
1,3-Dihydro-4-methyl-2H-1,5-benzodiazepin-2-on |
6276-48-8 |
C10H10N2O |
![(E)-2-Methoxy-4-(prop-1-enyl)phenol](/CAS/GIF/5932-68-3.gif) |
(E)-2-Methoxy-4-(prop-1-enyl)phenol |
5932-68-3 |
C10H12O2 |
![3-Amino-5-[(methylthio)methyl]oxazolidin-2-on](/CAS/GIF/25517-72-0.gif) |
3-Amino-5-[(methylthio)methyl]oxazolidin-2-on |
25517-72-0 |
C5H10N2O2S |
![Phosphonic acid, [[2-(6-amino-9H-purin-9-yl)propoxy]methyl]- (9CI)](/CAS/20210305/GIF/107021-20-5.gif) |
Phosphonic acid, [[2-(6-amino-9H-purin-9-yl)propoxy]methyl]- (9CI) |
107021-20-5 |
C9H14N5O4P |
![Sitagliptin EP Impurity 7](/) |
Sitagliptin EP Impurity 7 |
|
|
![Sitagliptin EP Impurity H](/) |
Sitagliptin EP Impurity H |
|
|
![7-Benzofurancarboxamide, 4-amino-5-chloro-2,3-dihydro-3-hydroxy-N-[1-(3-methoxypropyl)-4-piperidinyl]-](/CAS/20210305/GIF/2636673-48-6.gif) |
7-Benzofurancarboxamide, 4-amino-5-chloro-2,3-dihydro-3-hydroxy-N-[1-(3-methoxypropyl)-4-piperidinyl]- |
2636673-48-6 |
C18H26ClN3O4 |
![Beprostatin impurity 4](/) |
Beprostatin impurity 4 |
|
|
![Methyltosylcarbamat](/CAS/GIF/14437-03-7.gif) |
Methyltosylcarbamat |
14437-03-7 |
C9H11NO4S |
![(1R,2R,4S,5S,7s,9r)-9-butyl-9-methyl-7-((2-phenylacryloyl)oxy)-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium](/CAS/20211123/GIF/786598-71-8.gif) |
(1R,2R,4S,5S,7s,9r)-9-butyl-9-methyl-7-((2-phenylacryloyl)oxy)-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium |
786598-71-8 |
C21H28NO3+ |
![(+)-2-Ethoxy-4-(N-3-Methyl-1(S)-(2-(1-Piperidinyl)Phenyl)-Butyl)Carbamoylmethyl)](/CAS/GIF/147770-06-7.gif) |
(+)-2-Ethoxy-4-(N-3-Methyl-1(S)-(2-(1-Piperidinyl)Phenyl)-Butyl)Carbamoylmethyl) |
147770-06-7 |
C29H40N2O4 |
![4-Chloro-2-(chloromethyl)-3-Methyl Pyridine Hydrochloride](/CAS/GIF/152402-97-6.gif) |
4-Chloro-2-(chloromethyl)-3-Methyl Pyridine Hydrochloride |
152402-97-6 |
C7H8Cl3N |
![4-(3-CYANO-2-METHYLPROPIONYL)ACETAMILIDE](/CAS/GIF/42075-21-8.gif) |
4-(3-CYANO-2-METHYLPROPIONYL)ACETAMILIDE |
42075-21-8 |
|
![Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime]](/CAS/GIF/119699-81-9.gif) |
Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime] |
119699-81-9 |
C48H94N2O14Si2 |
![(R)-8-(3-aminopiperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-7-(3-oxobutyl)-3,7-dihydro-1H-purine-2,6-dione](/) |
(R)-8-(3-aminopiperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-7-(3-oxobutyl)-3,7-dihydro-1H-purine-2,6-dione |
|
|
![Isavuconazole Impurity 37](/) |
Isavuconazole Impurity 37 |
|
|
![N-((R)-1-(((R)-3-methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide](/CAS/20210305/GIF/1375004-39-9.gif) |
N-((R)-1-(((R)-3-methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide |
1375004-39-9 |
C29H39BN4O4 |
![Faropenem Degradation Impurity B](/) |
Faropenem Degradation Impurity B |
|
|
![2-chloro-1-(5-isopropoxy-5H-chromeno[2,3-b]pyridin-7-yl)propan-1-one](/) |
2-chloro-1-(5-isopropoxy-5H-chromeno[2,3-b]pyridin-7-yl)propan-1-one |
|
|
![Oxacillin Impurity 1](/CAS/20210305/GIF/36231-30-8.gif) |
Oxacillin Impurity 1 |
36231-30-8 |
C19H19N3O6S |
![Brivaracetam Impurity 33](/) |
Brivaracetam Impurity 33 |
|
|
![Arformoterol Impurity 24](/CAS/20210111/GIF/477552-93-5.gif) |
Arformoterol Impurity 24 |
477552-93-5 |
C19H24N2O3 |
![Pregabalin Impurity 99](/CAS/20210111/GIF/949890-75-9.gif) |
Pregabalin Impurity 99 |
949890-75-9 |
C16H23NO4 |
![Roxatidine Impurity 9](/CAS/20210111/GIF/87327-60-4.gif) |
Roxatidine Impurity 9 |
87327-60-4 |
C4H6O4 |
![Regofenib impurity K](/) |
Regofenib impurity K |
|
|
![Chlorpheniramine Impurity 4](/) |
Chlorpheniramine Impurity 4 |
|
|
![Peramivir Impurity 43](/) |
Peramivir Impurity 43 |
|
|
![N-(4-BROMOBUTYL)-7-(4-BROMOBUTOXY)-QUINOLINE-2(1H)-ONE](/StructureFile/ChemBookStructure22/GIF/CB0648431.gif) |
N-(4-BROMOBUTYL)-7-(4-BROMOBUTOXY)-QUINOLINE-2(1H)-ONE |
1076199-56-8 |
C17H21Br2NO2 |
![METHYL 2-[(2,5-DICHLOROBENZOYL)AMINO]ACETATE](/StructureFile/ChemBookStructure4/GIF/CB0665441.gif) |
METHYL 2-[(2,5-DICHLOROBENZOYL)AMINO]ACETATE |
338965-44-9 |
C10H9Cl2NO3 |
![4-(DIPHENYLMETHYL)-1-PIPERAZINEETHANOL DIHYDROCHLORIDE](/CAS/GIF/108983-83-1.gif) |
4-(DIPHENYLMETHYL)-1-PIPERAZINEETHANOL DIHYDROCHLORIDE |
108983-83-1 |
C19H26Cl2N2O |
![2-Piperazine-4-amino-6,7-dimethoxyquinazoline](/CAS/GIF/60547-97-9.gif) |
2-Piperazine-4-amino-6,7-dimethoxyquinazoline |
60547-97-9 |
C14H19N5O2 |
![N-ACETYL-4-BENZOQUINONE IMINE](/CAS/GIF/50700-49-7.gif) |
N-ACETYL-4-BENZOQUINONE IMINE |
50700-49-7 |
C8H7NO2 |
![Card-20(22)-enolid, 3-[(O-2,6-Dideoxy-β-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-, (3β,5β,12β)-](/CAS/GIF/31539-05-6.gif) |
Card-20(22)-enolid, 3-[(O-2,6-Dideoxy-β-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-, (3β,5β,12β)- |
31539-05-6 |
C47H74O17 |
![Sugammadex sodium Impurity 51](/) |
Sugammadex sodium Impurity 51 |
|
|
![Sugammadex sodium Impurity 42](/) |
Sugammadex sodium Impurity 42 |
|
|
![(S)-1-(2-(((1r,3R,5S,7S)-3,5-dihydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile](/) |
(S)-1-(2-(((1r,3R,5S,7S)-3,5-dihydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile |
|
|
![Mannitol EP impurity B](/) |
Mannitol EP impurity B |
|
|
![Mannitol EP impurity A](/) |
Mannitol EP impurity A |
|
|
![Peramivir Amino Carboxylic Isomerism Impurity](/) |
Peramivir Amino Carboxylic Isomerism Impurity |
|
|
![Peramivir Chlorinated Impurity](/) |
Peramivir Chlorinated Impurity |
|
|
![Brivaracetam Impurity 999](/) |
Brivaracetam Impurity 999 |
|
|
![Dasatinib impurity 48](/) |
Dasatinib impurity 48 |
|
|
![Pemetrexed Impurity 120](/) |
Pemetrexed Impurity 120 |
|
|
![Ticagrelor Impurity 101](/) |
Ticagrelor Impurity 101 |
|
|
![4-tosyl-1,4,8,11-tetraazabicyclo[9.3.1]pentadecane](/) |
4-tosyl-1,4,8,11-tetraazabicyclo[9.3.1]pentadecane |
|
|
![1-(3-((2,4-dimethylphenyl)thio)phenyl)piperazine hydrochloride](/) |
1-(3-((2,4-dimethylphenyl)thio)phenyl)piperazine hydrochloride |
2137793-92-9 |
|
![(R)-(-)-2-AMINOBUTANAMIDE HYDROCHLORIDE, 97%](/CAS/GIF/103765-03-3.gif) |
(R)-(-)-2-AMINOBUTANAMIDE HYDROCHLORIDE, 97% |
103765-03-3 |
C4H11ClN2O |
![Flomoxef Impurity 20 Sodium Salt](/CAS/20210305/GIF/2095697-77-9.gif) |
Flomoxef Impurity 20 Sodium Salt |
2095697-77-9 |
C15H18F2N6O7S2 |
![((2R,3S,4R)-3,4,5-trihydroxytetrahydrofuran-2-yl)methyl isobutyrate](/CAS/20211123/GIF/2591381-21-2.gif) |
((2R,3S,4R)-3,4,5-trihydroxytetrahydrofuran-2-yl)methyl isobutyrate |
2591381-21-2 |
C9H16O6 |
![3-Thiophenecarboxylic acid, 4-(bromomethyl)-2-[[(2,6-difluorophenyl)methyl](propoxycarbonyl)amino]-5-(4-nitrophenyl)-, ethyl ester](/CAS/20210305/GIF/2591260-07-8.gif) |
3-Thiophenecarboxylic acid, 4-(bromomethyl)-2-[[(2,6-difluorophenyl)methyl](propoxycarbonyl)amino]-5-(4-nitrophenyl)-, ethyl ester |
2591260-07-8 |
C25H23BrF2N2O6S |
![Cyclohexanecarboxylic acid, 2-[[[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]amino]carbonyl]-, (1R,2S)-rel-](/CAS/20210305/GIF/190582-37-7.gif) |
Cyclohexanecarboxylic acid, 2-[[[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]amino]carbonyl]-, (1R,2S)-rel- |
190582-37-7 |
C23H32N4O3S |
![Ivabradine Impurity II](/) |
Ivabradine Impurity II |
|
|
![(1R,2R,4S,5S,7r)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl 2-hydroxy-2,2-di(thiophen-2-yl)acetate](/CAS/20211123/GIF/792155-94-3.gif) |
(1R,2R,4S,5S,7r)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl 2-hydroxy-2,2-di(thiophen-2-yl)acetate |
792155-94-3 |
C18H19NO4S2 |
![Org49095](/CAS/20211123/GIF/2412952-95-3.gif) |
Org49095 |
2412952-95-3 |
C71H111NaO48S8 |
![Clopidogrel Impurity 55](/) |
Clopidogrel Impurity 55 |
|
|
![Cabozantinib impurity 43](/) |
Cabozantinib impurity 43 |
|
|
![Cabozantinib impurity 75](/) |
Cabozantinib impurity 75 |
|
|
![Cabozantinib impurity 73](/) |
Cabozantinib impurity 73 |
|
|
![Canagliflozin Impurity 69](/) |
Canagliflozin Impurity 69 |
|
|
![Dapoxetine impurity 65](/) |
Dapoxetine impurity 65 |
|
|
![Dapoxetine impurity 59](/) |
Dapoxetine impurity 59 |
|
|
![PeraMpanel](/CAS/20210111/GIF/380919-34-6.gif) |
PeraMpanel |
380919-34-6 |
C23H17N3O2 |
![Empagliflozin Impurity 83](/) |
Empagliflozin Impurity 83 |
|
|
![Ambroxol Imp.O](/CAS/20210111/GIF/1807328-39-7.gif) |
Ambroxol Imp.O |
1807328-39-7 |
C13H12Br2N2O |
![Olopatadine Impurity 10 HBr](/CAS/20211123/GIF/4174-83-8.gif) |
Olopatadine Impurity 10 HBr |
4174-83-8 |
C22H26Br2NP |
![Iohexol Impurity Q](/) |
Iohexol Impurity Q |
|
|
![Diphenidol Impurity 2](/CAS/20210305/GIF/63645-18-1.gif) |
Diphenidol Impurity 2 |
63645-18-1 |
C16H17ClO |
![(2,5-dibromophenyl)(4-ethoxyphenyl)methanone](/CAS/20210111/GIF/1713015-63-4.gif) |
(2,5-dibromophenyl)(4-ethoxyphenyl)methanone |
1713015-63-4 |
C15H12Br2O2 |
![Flucloxacillin Impurity 1](/) |
Flucloxacillin Impurity 1 |
|
|
![Rocuronium Bromide Impurity 39](/) |
Rocuronium Bromide Impurity 39 |
|
|
![Ticagrelor Intermediate 1 D-Tartrate](/CAS/20210111/GIF/2376278-72-5.gif) |
Ticagrelor Intermediate 1 D-Tartrate |
2376278-72-5 |
C14H25NO10 |
![2-(3,5-dicyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid](/CAS/20210111/GIF/2428631-65-4.gif) |
2-(3,5-dicyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid |
2428631-65-4 |
C17H15N3O3S |
![Roxadustat impurity ZZ5](/CAS/20181212/GIF/CB08058137.gif) |
Roxadustat impurity ZZ5 |
|
C17H12ClNO4 |
![Lenvatinib impurity LFZZ-7](/CAS/20181212/GIF/CB08058142.gif) |
Lenvatinib impurity LFZZ-7 |
|
C11H9ClN2O2 |
![Rosuvastatin Impurity 119](/) |
Rosuvastatin Impurity 119 |
|
|
![Rosuvastatin Impurity 105](/) |
Rosuvastatin Impurity 105 |
|
|
![(2R,3R,4R,5S,6R)-2-(acetoxymethyl)-6-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate](/CAS/20211123/GIF/1620758-27-1.gif) |
(2R,3R,4R,5S,6R)-2-(acetoxymethyl)-6-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate |
1620758-27-1 |
C31H35ClO11 |
![Febuxostat Impurity 99](/) |
Febuxostat Impurity 99 |
|
|
![Furosemide Impurity 20](/) |
Furosemide Impurity 20 |
|
|
![1-((2S,3S)-3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-4-(1-((methyl(3-((2-(methylamino)acetoxy)methyl)pyridin-2-yl)carbamoyl)oxy)ethyl)-1H-1,2,4-triazol-4-ium](/) |
1-((2S,3S)-3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-4-(1-((methyl(3-((2-(methylamino)acetoxy)methyl)pyridin-2-yl)carbamoyl)oxy)ethyl)-1H-1,2,4-triazol-4-ium |
|
|
![(3R,4R,5S)-ethyl 4,5-diacetamido-3-(pentan-3-yloxy)cyclohex-1- enecarboxylate](/CAS/20210111/GIF/1191921-01-3.gif) |
(3R,4R,5S)-ethyl 4,5-diacetamido-3-(pentan-3-yloxy)cyclohex-1- enecarboxylate |
1191921-01-3 |
C18H30N2O5 |
![Ticagrelor Impurity 109](/) |
Ticagrelor Impurity 109 |
|
|
![Ticagrelor Impurity 134](/) |
Ticagrelor Impurity 134 |
|
|
![2-Propenamide, 2-cyano-3-(3,4-dihydroxyphenyl)-N,N-diethyl-, (2E)-](/CAS/20200611/GIF/1217439-96-7.gif) |
2-Propenamide, 2-cyano-3-(3,4-dihydroxyphenyl)-N,N-diethyl-, (2E)- |
1217439-96-7 |
C14H16N2O3 |
![Benzonitrile, 4,4'-[[2,2'-bis(hydroxymethyl)[1,1'-biphenyl]-4,4'-diyl]bis(oxy)]bis-](/CAS/20200611/GIF/2254541-79-0.gif) |
Benzonitrile, 4,4'-[[2,2'-bis(hydroxymethyl)[1,1'-biphenyl]-4,4'-diyl]bis(oxy)]bis- |
2254541-79-0 |
C28H20N2O4 |
![Benzoic acid, 3-(butylamino)-5-[(butylamino)sulfonyl]-4-phenoxy-](/CAS/20200611/GIF/28469-01-4.gif) |
Benzoic acid, 3-(butylamino)-5-[(butylamino)sulfonyl]-4-phenoxy- |
28469-01-4 |
C21H28N2O5S |
![Acetamide, N-[9-[[2-(acetyloxy)-1-(hydroxymethyl)ethoxy]methyl]-6,9-dihydro-6-oxo-1H-purin-2-yl]-](/CAS/20200611/GIF/298197-26-9.gif) |
Acetamide, N-[9-[[2-(acetyloxy)-1-(hydroxymethyl)ethoxy]methyl]-6,9-dihydro-6-oxo-1H-purin-2-yl]- |
298197-26-9 |
C13 H17 N5 O6 |
![Topiroxostat Impurity 46](/) |
Topiroxostat Impurity 46 |
|
|
![Topiroxostat Impurity 43](/) |
Topiroxostat Impurity 43 |
|
|
![N-(2-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl)ethyl)-N-methyl formamide](/CAS/20210111/GIF/1643948-40-6.gif) |
N-(2-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl)ethyl)-N-methyl formamide |
1643948-40-6 |
C17H25NO3 |
![Regorafenib Impurity 40](/) |
Regorafenib Impurity 40 |
|
|
![3-Quinolinecarboxylic acid, 1-cyclopropyl-7-fluoro-1,4-dihydro-6,8-dimethoxy-4-oxo-, ethyl ester](/CAS/20210111/GIF/2489671-14-7.gif) |
3-Quinolinecarboxylic acid, 1-cyclopropyl-7-fluoro-1,4-dihydro-6,8-dimethoxy-4-oxo-, ethyl ester |
2489671-14-7 |
C17H18FNO5 |
![Bisoprolol Impurity 17](/CAS/20210111/GIF/109791-19-7.gif) |
Bisoprolol Impurity 17 |
109791-19-7 |
C15H23NO5 |
![Furosemide Impurity 5](/CAS/20210111/GIF/518336-22-6.gif) |
Furosemide Impurity 5 |
518336-22-6 |
C12H10ClNO3 |
![Lumateperone Impurity 2](/CAS/20210111/GIF/313544-32-0.gif) |
Lumateperone Impurity 2 |
313544-32-0 |
C16H19N3O3 |
![Pramipexole Impurity 55](/CAS/20210111/GIF/959012-83-0.gif) |
Pramipexole Impurity 55 |
959012-83-0 |
C8H11NO2 |
![INDEX NAME NOT YET ASSIGNED](/CAS/20211123/GIF/2438857-80-6.gif) |
INDEX NAME NOT YET ASSIGNED |
2438857-80-6 |
C27H22F2N6O5 |
![Nicergoline Impurity 01](/) |
Nicergoline Impurity 01 |
|
|
![impurity 38](/) |
impurity 38 |
|
|